DMH4

CAS No. 515880-75-8

DMH4( —— )

Catalog No. M33846 CAS No. 515880-75-8

DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 71 In Stock
10MG 102 In Stock
25MG 168 In Stock
50MG 244 In Stock
100MG 360 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DMH4
  • Note
    Research use only, not for human use.
  • Brief Description
    DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
  • Description
    DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    515880-75-8
  • Formula Weight
    400.47
  • Molecular Formula
    C24H24N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CN1CCOCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hao J, et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010 Feb 19;5(2):245-53.??
molnova catalog
related products
  • Semaxinib

    Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor.

  • VEGFR-3-IN-1

    VEGFR-3-IN-1 is a novel, potent, and selective VEGFR3 inhibitor with an IC50 of 110.4 nM.

  • Motesanib

    A potent, orally bioavailable, multikinase inhibitor inhibitor of VEGFR1/2/3, PDGFR and c-Kit with IC50 of 2-6 nM, 84 nM and 8 nM, respectively.